<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04111718</url>
  </required_header>
  <id_info>
    <org_study_id>ABx-prp-001</org_study_id>
    <nct_id>NCT04111718</nct_id>
  </id_info>
  <brief_title>The Impact of Procedural Awareness of Knee Injections for Osteoarthritis on Patient Perceptions of Effectiveness</brief_title>
  <official_title>The Impact of Procedural Awareness of Knee Injections for Osteoarthritis on Patient Perceptions of Effectiveness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ArthroBiologix Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ArthroBiologix Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether outcomes for patients receiving
      intra-articular platelet-rich plasma (PRP) injections for knee osteoarthritis are influenced
      by observation of the preparatory steps to the procedure. The viewing of the steps involved
      in the administration of PRP may increase the effectiveness of the treatment in comparison to
      patients who have not observed the preparatory steps.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS Pain</measure>
    <time_frame>12 weeks</time_frame>
    <description>Visual analog scale pain on a 0-10 scale, with higher scores indicating worse pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Patient reported knee osteoarthritis index with subscores of pain, function and stiffness. The range of scores on the WOMAC is from 0-96, with higher scores indicating worse outcomes. The subscore of pain is on a scale of 0-20, the subscore of stiffness is 0-8, and the subscale of function is 0-68. The scores of the subscales are summed in order to get the total score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of motion</measure>
    <time_frame>12 weeks</time_frame>
    <description>Range of motion in the knee from full extension to full flexion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Form 12 (SF-12) Functional outcome assessment</measure>
    <time_frame>12 weeks</time_frame>
    <description>Health-related quality of life measure on a scale from 0-100, where higher scores indicate better function.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">158</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>Viewing of preparation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patient will be in the room for the preparation of the PRP and will receive a description of the centrifuge process from the physician administering the injection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blinded to preparation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The patient will leave the room after their blood is drawn and will not view the preparation of the PRP, and will also not receive a description of the centrifuge process.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Platelet-rich plasma (PRP)</intervention_name>
    <description>Autologous platelet-rich plasma which will be derived from blood drawn from the patient.</description>
    <arm_group_label>Blinded to preparation</arm_group_label>
    <arm_group_label>Viewing of preparation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Viewing of preparation</intervention_name>
    <description>The patient will receive a description of the preparation process and will view the preparation in the centrifuge.</description>
    <arm_group_label>Viewing of preparation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult men or women ages 50-80 years

          -  Diagnosis of symptomatic osteoarthritis of the knee based on clinical and radiographic
             criteria

          -  Provision of informed consent

        Exclusion Criteria:

          -  Patients with inflammatory osteoarthritis

          -  Open wounds or sores over the knee joint

          -  Patients that will likely have problems, in the judgement of the investigators, with
             maintaining follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Moin Khan, FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Steven Phillips, MSc</last_name>
    <phone>289-337-5717</phone>
    <email>steve.phillips@myorthoevidence.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>ArthroBiologix</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Rabinovich, FRCSC</last_name>
      <phone>289-389-8181</phone>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 30, 2019</study_first_submitted>
  <study_first_submitted_qc>September 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2019</study_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

